During the past decade, fibrate use more than doubled in the U.S. but remained relatively stable in Canada, according to a study just published in JAMA. In January 2002, fibrate use was similar in the two countries: 336 prescriptions per 100,000 population in the U.S. versus 402 per 100,000 in Canada. By December 2009, the…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

In a series of blog posts on CardioExchange, Samuel Goldhaber, Director of the Venous Thromboembolism Research Group in the Cardiovascular Division at Brigham and Women’s Hospital, has been guiding us on best practices around dabigatran. Recently, he teamed up with Elaine Hylek, Director of the Thrombosis and Anticoagulation Service at Boston University School of Medicine,…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

CardioExchange welcomes David J. Cohen, Director of Cardiovascular Research at St. Luke’s Mid America Heart Institute in Kansas City, Missouri, to discuss the latest analysis from the SYNTAX randomized trial. The study has just been published in the New England Journal of Medicine, and Dr. Cohen is the lead author. Questions to Dr. Cohen come…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

A qualitative study just published in the Annals of Internal Medicine outlines some important distinctions between hospitals that have the lowest AMI mortality rates in the U.S and those that have the highest. The key factor? A supportive organizational culture. Here, study investigator Leslie Curry, PhD, MPH walks us through what that means and how…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.